Availability of advanced immunofluorescence assays kits and reagents, growing healthcare burden of chronic diseases, and increasing investments in healthcare sector are key factors driving market growth
The global immunofluorescence assay (IFA) market size is expected to reach USD 4.01 billion by 2028 at a CAGR of 6.3%, according to the latest report by Reports and Data. Increasing global healthcare burden of chronic and infectious diseases, rising application of immunofluorescence assays in clinical diagnostics and research, and growing investments and expenditure in healthcare sector are key factors expected to drive market revenue growth over the forecast period.
Immunofluorescence assay is a microscopic technique primarily used on microbiological samples, which uses the specificity of antibodies to their antigens. Antibodies are labelled with fluorescent dye and the subsequently formed antigen-antibody complex can be visualized using fluorescent microscope. Immunofluorescence assays are of two types: direct immunofluorescence, which uses primary antibody that is conjugated to fluorescent dye and indirect immunofluorescence in which a secondary antibody is conjugated with fluorophore against a primary antibody that is used for detection. IFA is a standardized technique extensively used in virology to determine the presence of antibodies by their specificity to viral antigens that are expressed by the infected cells. Immunofluorescence assays have also been used to develop antibodies against SARS-CoV-2 to enable efficient detection and curb the spread of the virus, and this trend is expected to continue going ahead.
Request Free Sample Copy (To Understand the Complete Structure of this Report [Summary + TOC])@ https://www.reportsanddata.com/sample-enquiry-form/4006
Growth in the historic period resulted from the rapid growth in the elderly population, strong economic growth in emerging markets, decline in oil prices, and health insurance reforms globally. Factors that negatively affected growth in the historic period were low healthcare access, shortages of skilled human resources, difficulty in manufacturing biologics, and regulatory changes.
Going forward, faster economic growth, technological developments and the increasing prevalence of diseases due to rising busy and sedentary lifestyles will drive the growth. Factors that could hinder the growth of this market in the future are rising interest rates, increasing awareness of alternative therapies and natural remedies, government provisions in healthcare services, and stringent government regulations.
North America is the largest market for healthcare, followed by Asia-Pacific, Western Europe and then the other regions. Due to favorable regulations and policies in these regions, healthcare industry is rapidly growing. As the market in developed countries is nearly saturated, market players have shifted their focus toward the developing regions, especially the emerging economies of Asia Pacific.
Order this Reports @ https://www.reportsanddata.com/report-pricing/4006
The prominent factors favoring market growth include increasing launches and initiatives by the market players to provide rapid treatment for addressing the diseases of the patients in the healthcare industry. Market-trend-based strategies for the healthcare market include increasing the adoption of bundled payments, using digital tools, increasing collaborations across industries and companies, focusing on the development of new medicines, and adopting hybrid imaging technology. Players adopted strategies in the healthcare industry include acquiring companies in similar industries to expand their presence and focusing on offering quality products and services.
The competitive landscape section of the report discusses in detail the company overview, product and services portfolio, business expansion plans, production and manufacturing capacity, financial standing, and global market position. It further sheds light on the recent mergers and acquisitions, collaborations, partnerships, corporate and government deals, agreements, and product launches.
Top companies operating in the market and profiled in the report include:
Thermo Fisher Scientific, Inc., Merck KGaA, Danaher Corporation, Abcam Plc, Bio-Rad Laboratories, Inc., PerkinElmer Inc., Werfen Company, Agilent Technologies, Cell Signaling Technology, Inc., MEDIPAN GmbH, Enzo Biochem, Inc., Becton, Dickinson and Company, Bruker Corporation, and EpiGentek Group, and others.
Further, the report segments the Immunofluorescence Assay (IFA) market on the basis of product types, applications, end-use industries, and technology among others. The report offers insights into key factors influencing the revenue growth of the segment and provides information about lucrative investment opportunities to stakeholders, investors, and clients.
Immunofluorescence Assay (IFA) Market Segmentation:
Product Outlook (Revenue, USD Billion; 2018-2028)
- Consumables & Accessories
Type Outlook (Revenue, USD Billion; 2018-2028)
- Direct immunofluorescence
- Indirect immunofluorescence
Disease Outlook (Revenue, USD Billion; 2018-2028)
- Cardiovascular diseases
- Autoimmune diseases
- Infectious diseases
End-use Industry Outlook (Revenue, USD Billion; 2018-2028)
- Pharmaceutical & Biotechnology Companies
- Academic & Research Institutes
- Hospitals & Diagnostic Centers
Regional Analysis covers:
- North America
- Rest of EU
- Asia Pacific
- South Korea
- Rest of APAC
- Latin America
- Rest of Latin America
- Middle East & Africa
- Saudi Arabia
- South Africa
- Rest of MEA
Request a customization of the report @ https://www.reportsanddata.com/request-customization-form/4006
Thank you for reading our report. To know more about the customization feature, please get in touch with us and our team will ensure the report is customized to meet your requirements.
Explore More Industry Research by Reports and Data:
Neuroprosthetics Market @ https://www.biospace.com/article/neuroprosthetics-market-will-reach-nearly-usd-27-05-billion-expanding-at-a-cagr-of-12-1-percent-during-the-forecast-period-of-2030-reports-and-data/
Hematology Diagnostics Market @ https://www.biospace.com/article/hematology-diagnostics-market-will-reach-nearly-usd-10-20-billion-expanding-at-a-cagr-of-4-93-percent-during-the-forecast-period-of-2030-reports-and-data/
About Reports and Data
Reports and Data is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target and analyze consumer behavior shifts across demographics, across industries and help client’s make a smarter business decision. We offer market intelligence studies ensuring relevant and fact-based research across a multiple industries including Healthcare, Technology, Chemicals, Power and Energy. We consistently update our research offerings to ensure our clients are aware about the latest trends existent in the market. Reports and Data has a strong base of experienced analysts from varied areas of expertise.
Head of Business Development
Reports and Data | Web: www.reportsanddata.com
Direct Line: +1-212-710-1370
E-mail: [email protected]